GRI Index

GRI Guideline			Corresponding Pfizer Material		UNGC Principle
1.1	Statement from the most senior decision-maker of the organization (e.g., CEO, chair, or equivalent senior position) about the relevance of sustainability to the organization and its strategy.		CEO Letter
1.2	Description of key impacts, risks, and opportunities.				8

Covered

Partially Covered

Not Covered

GRI Guideline			Corresponding Pfizer Material		UNGC Principle
2.1	Name of the organization.
2.2	Primary brands, products, and/or services.		Our Business
2.3	Operational structure of the organization, including main divisions, operating companies, subsidiaries, and joint ventures.
2.4	Location of organization's headquarters.
2.5	Number of countries where the organization operates, and names of countries with either major operations or that are specifically relevant to the sustainability issues covered in the report.
2.6	Nature of ownership and legal form.
2.7	Markets served (including geographic breakdown, sectors served, and types of customers/beneficiaries).
2.8	Scale of the reporting organization		About This Review
2.9	Significant changes during the reporting period regarding size, structure, or ownership		CEO Letter
2.10	Awards received in the reporting period.

Covered

Partially Covered

Not Covered

Report Profile

GRI Guideline			Corresponding Pfizer Material		UNGC Principle
3.1	Reporting period (e.g., fiscal/calendar year) for information provided.
3.2	Date of most recent previous report (if any).
3.3	Reporting cycle (annual, biennial, etc.)		About This Review
3.4	Contact point for questions regarding the report or its contents.		Corporate and Shareholder Information

Report Scope and Boundary

GRI Guideline			Corresponding Pfizer Material		UNGC Principle
3.5	Process for defining report content.		About This Review Stakeholder Engagement
3.6	Boundary of the report (e.g., countries, divisions, subsidiaries, leased facilities, joint ventures, suppliers). See GRI Boundary Protocol for further guidance.		About This Review
3.7	State any specific limitations on the scope or boundary of the report.		N/A
3.8	Basis for reporting on joint ventures, subsidiaries, leased facilities, outsourced operations, and other entities that can significantly affect comparability from period to period and/or between organizations.		About This Review
3.9	Data measurement techniques and the bases of calculations, including assumptions and techniques underlying estimations applied to the compilation of the Indicators and other information in the report.
3.10	Explanation of the effect of any re-statements of information provided in earlier reports, and the reasons for such re-statement (e.g., mergers/acquisitions, change of base years/periods, nature of business, measurement methods).		N/A
3.11	Significant changes from previous reporting periods in the scope, boundary, or measurement methods applied in the report.		N/A

GRI Content Index

GRI Guideline			Corresponding Pfizer Material		UNGC Principle
3.12	Table identifying the location of the Standard Disclosures in the report.		About This Review

Assurance

GRI Guideline			Corresponding Pfizer Material		UNGC Principle
3.13	Policy and current practice with regard to seeking external assurance for the report. If not included in the assurance report accompanying the sustainability report, explain the scope and basis of any external assurance provided. Also explain the relationship between the reporting organization and the assurance provider(s).		N/A

Covered

Partially Covered

Not Covered

GOVERNANCE

GRI Guideline			Corresponding Pfizer Material		UNGC Principle
4.1	Governance structure of the organization, including committees under the highest governance body responsible for specific tasks, such as setting strategy or organizational oversight.		Corporate Governance
4.2	Indicate whether the Chair of the highest governance body is also an executive officer (and, if so, their function within the organization's management and the reasons for this arrangement).		Corporate Governance
4.3	For organizations that have a unitary board structure, state the number of members of the highest governance body that are independent and/or non- executive members.
4.4	Mechanisms for shareholders and employees to provide recommendations or direction to the highest governance body.
4.5	Linkage between compensation for members of the highest governance body, senior managers, and executives (including departure arrangements), and the organization's performance (including social and environmental performance).		Executive Compensation Compensation Discussion and Analysis section of Pfizer's 2010 Proxy Statement
4.6	Processes in place for the highest governance body to ensure conflicts of interest are avoided.		Ethics
4.7	Process for determining the qualifications and expertise of the members of the highest governance body for guiding the organization's strategy on economic, environmental, and social topics.
4.8	Internally developed statements of mission or values, codes of conduct, and principles relevant to economic, environmental, and social performance and the status of their implementation.		Clinical Trials Stem Cells Bioethics Ethical Sales and Marketing Corporate Governance Ethics Public Policy
4.9	Procedures of the highest governance body for overseeing the organization's identification and management of economic, environmental, and social performance, including relevant risks and opportunities, and adherence or compliance with internationally agreed standards, codes of conduct, and principles.
4.10	Processes for evaluating the highest governance body's own performance, particularly with respect to economic, environmental, and social performance.

COMMITMENTS TO EXTERNAL INITIATIVES

GRI Guideline			Corresponding Pfizer Material		UNGC Principle
4.11	Explanation of whether and how the precautionary approach or principle is addressed by the organization.		Ethical Sales and Marketing Environment		7
4.12	Externally developed economic, environmental, and social charters, principles, or other initiatives to which the organization subscribes or endorses.		Clinical Trials Ethical Sales and Marketing Human Rights Manufacturing and Supply Chain
4.13	Memberships in associations (such as industry associations) and/or national/international advocacy organizations in which the organization: - has positions in governance bodies; - participates in projects or committees; - provides substantive funding beyond routine membership dues; - views membership as strategic.		Global EHS Partnerships

STAKEHOLDER ENGAGEMENT

GRI Guideline			Corresponding Pfizer Material		UNGC Principle
4.14	List of stakeholder groups engaged by the organization.
4.15	Basis for identification and selection of stakeholders with whom to engage.		Stakeholder Engagement
4.16	Approaches to stakeholder engagement, including frequency of engagement by type and by stakeholder group.		Stakeholder Engagement
4.17	Key topics and concerns that have been raised through stakeholder engagement, and how the organization has responded to those key topics and concerns, including through its reporting.

Covered

Partially Covered

Not Covered

Economic Disclosures

The economic dimension of sustainability concerns the organization's impacts on the economic conditions of its stakeholders and on economic systems at local, national, and global levels. The Economic Indicators illustrate:

• Flow of capital among different stakeholders; and
• Main economic impacts of the organization throughout society.

Financial performance is fundamental to understanding an organization and its own sustainability. However, this information is normally already reported in financial accounts. What is often reported less, and is frequently desired by users of sustainability reports, is the organization's contribution to the sustainability of a larger economic system.

Disclosure on Management Approach (Economy)

Economic Performance Indicators

Environmental Disclosures

The environmental dimension of sustainability concerns an organization's impacts on living and non-living natural systems, including ecosystems, land, air, and water. Environmental Indicators cover performance related to inputs (e.g., material, energy, water) and outputs (e.g., emissions, effluents, waste). In addition, they cover performance related to biodiversity, environmental compliance, and other relevant information such as environmental expenditure and the impacts of products and services.

Disclosure on Management Approach (Environment)

Environmental Performance Indicators

Social Disclosures

The social dimension of sustainability concerns the impacts an organization has on the social systems within which it operates. The GRI Social Performance Indicators identify key Performance Aspects surrounding labor practices, human rights, society, and product responsibility.

Labor Practices and Decent Work

Disclosure on Management Approach (Labor Practices and Decent Work)

Labor Practices and Decent Work Performance Indicators

Human Rights

Disclosure on Management Approach (Human Rights)

Human Rights Performance Indicators

Society

Disclosure on Management Approach (Society)

Society Performance Indicators

Product Responsibility

Disclosure on Management Approach (Product Responsibility)

Product Responsibility Performance Indicators

Covered

Partially Covered

Not Covered